Early catheter ablation for AF after HF hospitalistation may improve long-term outcomes Dr. Kamal Kant Kohli15 Sept 2023 9:45 AM ISTEarly catheter ablation (CA) for atrial fibrillation (AF) in patients with heart failure (HF) has shown promising results in improving long-term...
TyG index simple and cost-effective marker for early detection of people at high risk of HF Medha Baranwal13 Sept 2023 10:45 AM ISTIran: Triglyceride-glucose (TyG) index has demonstrated diagnostic ability in distinguishing heart failure (HF) patients from non-HF individuals, a...
High BP while lying down tied to higher risk of heart health complications Dr. Kamal Kant Kohli11 Sept 2023 9:00 AM ISTUSA: A recent study has suggested that people with known risk factors for heart disease and stroke may benefit from having their blood pressure (BP)...
Critically ill heart failure patients with increased TyG index face greater risk of acute kidney injury Medha Baranwal5 Sept 2023 11:30 AM ISTChina: An analysis of the MIMIC-IV database has revealed the triglyceride glucose (TyG) index to be a robust and independent predictor of acute kidney...
Natriuresis-guided diuretic therapy improves diuresis and natriuresis in patients with heart failure Medha Baranwal4 Sept 2023 10:45 AM ISTNetherlands: A recent study published in Nature Medicine suggests that natriuresis-guided therapy could be a first step toward personalized treatment...
Clozapine, but not olanzapine or quetiapine, linked with higher perimyocarditis and HF risk Dr. Kamal Kant Kohli2 Sept 2023 9:45 AM ISTA recent population-based study published in Psychiatry Research by Eric Clapham and colleagues has studied concerns about associations between the...
SGLT2 inhibitors failed to improve survival in patients hospitalised with COVID-19 Dr. Kamal Kant Kohli31 Aug 2023 10:00 AM ISTUSA: Findings from a recent study failed to support the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients hospitalized with...
ESC 2023 Update: Trial demonstrates potential of acoramidis for transthyretin amyloid cardiomyopathy Dr. Kamal Kant Kohli31 Aug 2023 9:30 AM ISTAcoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with placebo, according to late breaking...
Anticoagulation with edoxaban fails in patients with atrial high-rate episodes Dr. Kamal Kant Kohli30 Aug 2023 10:30 AM ISTGermany: Anticoagulation with edoxaban fails to significantly reduce the incidence of a composite of stroke, cardiovascular death, or systemic...
ESC 2023 Update: Traditional Chinese medicine qiliqiangxin shows meaningful clinical benefits in patients with HF Dr. Kamal Kant Kohli29 Aug 2023 9:45 AM ISTChina: A recent study has supported the role of the traditional Chinese medicine qiliqiangxin as an adjunct therapy for treating heart failure. The...
ESC 2023 Update: Iron therapy tied to reduced hospitalization, CV death in iron-deficient heart failure patients: Study Dr. Kamal Kant Kohli28 Aug 2023 10:45 AM ISTPoland: A recent study has suggested considering intravenous ferric carboxymaltose (FCM) in iron-deficient patients with heart failure and reduced or...
Management of Heart Failure: ESC Updates Guidelines Dr. Kamal Kant Kohli28 Aug 2023 10:00 AM ISTCanada: The European Society of Cardiology (ESC) has taken a significant stride in the field of heart failure management with a focused update to...
